1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
2. DeSantis CE, Ma J, Goding Sauer A, Newman LA, Jemal A: Breast cancer statistics, 2017, racial disparity in mortality by state. CA Cancer J Clin 2017, 67(6):439-448.
3. McDonald ES, Clark AS, Tchou J, Zhang P, Freedman GM: Clinical Diagnosis and Management of Breast Cancer. J Nucl Med 2016, 57 Suppl 1:9s-16s.
4. Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA et al: Molecular portraits of human breast tumours. Nature 2000, 406(6797):747-752.
5. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S et al: Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A 2003, 100(14):8418-8423.
6. Sørlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS et al: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001, 98(19):10869-10874.
7. Dent R, Trudeau M, Pritchard KI, Hanna WM, Kahn HK, Sawka CA, Lickley LA, Rawlinson E, Sun P, Narod SA: Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res 2007, 13(15 Pt 1):4429-4434.
8. von Minckwitz G, Blohmer JU, Costa SD, Denkert C, Eidtmann H, Eiermann W, Gerber B, Hanusch C, Hilfrich J, Huober J et al: Response-guided neoadjuvant chemotherapy for breast cancer. J Clin Oncol 2013, 31(29):3623-3630.
9. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. Lancet Oncol 2018, 19(1):27-39.
10. Aronson SJ, Rehm HL: Building the foundation for genomics in precision medicine. Nature 2015, 526(7573):336-342.
11. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A: Global cancer statistics, 2012. CA Cancer J Clin 2015, 65(2):87-108.
12. Kamb A: What's wrong with our cancer models? Nat Rev Drug Discov 2005, 4(2):161-165.
13. Caponigro G, Sellers WR: Advances in the preclinical testing of cancer therapeutic hypotheses. Nat Rev Drug Discov 2011, 10(3):179-187.
14. Whittle JR, Lewis MT, Lindeman GJ, Visvader JE: Patient-derived xenograft models of breast cancer and their predictive power. Breast Cancer Res 2015, 17(1):17.
15. Cheon DJ, Orsulic S: Mouse models of cancer. Annu Rev Pathol 2011, 6:95-119.
16. Carmon KS, Gong X, Lin Q, Thomas A, Liu Q: R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/beta-catenin signaling. Proc Natl Acad Sci U S A 2011, 108(28):11452-11457.
17. Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, Stange DE, van Es JH, Abo A, Kujala P, Peters PJ et al: Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 2009, 459(7244):262-265.
18. de Lau W, Barker N, Low TY, Koo BK, Li VS, Teunissen H, Kujala P, Haegebarth A, Peters PJ, van de Wetering M et al: Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature 2011, 476(7360):293-297.
19. Jung P, Sato T, Merlos-Suárez A, Barriga FM, Iglesias M, Rossell D, Auer H, Gallardo M, Blasco MA, Sancho E et al: Isolation and in vitro expansion of human colonic stem cells. Nat Med 2011, 17(10):1225-1227.
20. Sato T, Stange DE, Ferrante M, Vries RG, Van Es JH, Van den Brink S, Van Houdt WJ, Pronk A, Van Gorp J, Siersema PD et al: Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. Gastroenterology 2011, 141(5):1762-1772.
21. Boj SF, Hwang CI, Baker LA, Chio, II, Engle DD, Corbo V, Jager M, Ponz-Sarvise M, Tiriac H, Spector MS et al: Organoid models of human and mouse ductal pancreatic cancer. Cell 2015, 160(1-2):324-338.
22. Chua CW, Shibata M, Lei M, Toivanen R, Barlow LJ, Bergren SK, Badani KK, McKiernan JM, Benson MC, Hibshoosh H et al: Single luminal epithelial progenitors can generate prostate organoids in culture. Nat Cell Biol 2014, 16(10):951-961, 951-954.
23. Karthaus WR, Iaquinta PJ, Drost J, Gracanin A, van Boxtel R, Wongvipat J, Dowling CM, Gao D, Begthel H, Sachs N et al: Identification of multipotent luminal progenitor cells in human prostate organoid cultures. Cell 2014, 159(1):163-175.
24. Bartfeld S, Bayram T, van de Wetering M, Huch M, Begthel H, Kujala P, Vries R, Peters PJ, Clevers H: In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection. Gastroenterology 2015, 148(1):126-136.e126.
25. Kessler M, Hoffmann K, Brinkmann V, Thieck O, Jackisch S, Toelle B, Berger H, Mollenkopf HJ, Mangler M, Sehouli J et al: The Notch and Wnt pathways regulate stemness and differentiation in human fallopian tube organoids. Nat Commun 2015, 6:8989.
26. Maimets M, Rocchi C, Bron R, Pringle S, Kuipers J, Giepmans BN, Vries RG, Clevers H, de Haan G, van Os R et al: Long-Term In Vitro Expansion of Salivary Gland Stem Cells Driven by Wnt Signals. Stem Cell Reports 2016, 6(1):150-162.
27. DeWard AD, Cramer J, Lagasse E: Cellular heterogeneity in the mouse esophagus implicates the presence of a nonquiescent epithelial stem cell population. Cell Rep 2014, 9(2):701-711.
28. Rock JR, Onaitis MW, Rawlins EL, Lu Y, Clark CP, Xue Y, Randell SH, Hogan BL: Basal cells as stem cells of the mouse trachea and human airway epithelium. Proc Natl Acad Sci U S A 2009, 106(31):12771-12775.
29. Turco MY, Gardner L, Hughes J, Cindrova-Davies T, Gomez MJ, Farrell L, Hollinshead M, Marsh SGE, Brosens JJ, Critchley HO et al: Long-term, hormone-responsive organoid cultures of human endometrium in a chemically defined medium. Nat Cell Biol 2017, 19(5):568-577.
30. Sachs N, de Ligt J, Kopper O, Gogola E, Bounova G, Weeber F, Balgobind AV, Wind K, Gracanin A, Begthel H et al: A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity. Cell 2018, 172(1-2):373-386.e310.
31. Drost J, Clevers H: Organoids in cancer research. Nat Rev Cancer 2018, 18(7):407-418.
32. Vlachogiannis G, Hedayat S, Vatsiou A, Jamin Y, Fernández-Mateos J, Khan K, Lampis A, Eason K, Huntingford I, Burke R et al: Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science 2018, 359(6378):920-926.
33. van de Wetering M, Francies HE, Francis JM, Bounova G, Iorio F, Pronk A, van Houdt W, van Gorp J, Taylor-Weiner A, Kester L et al: Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell 2015, 161(4):933-945.
34. Ogston KN, Miller ID, Payne S, Hutcheon AW, Sarkar TK, Smith I, Schofield A, Heys SD: A new histological grading system to assess response of breast cancers to primary chemotherapy: prognostic significance and survival. Breast 2003, 12(5):320-327.
35. Wang-Lopez Q, Chalabi N, Abrial C, Radosevic-Robin N, Durando X, Mouret-Reynier MA, Benmammar KE, Kullab S, Bahadoor M, Chollet P et al: Can pathologic complete response (pCR) be used as a surrogate marker of survival after neoadjuvant therapy for breast cancer? Crit Rev Oncol Hematol 2015, 95(1):88-104.
36. Brennan M, Lim B: The Actual Role of Receptors as Cancer Markers, Biochemical and Clinical Aspects: Receptors in Breast Cancer. Adv Exp Med Biol 2015, 867:327-337.
37. Dai X, Xiang L, Li T, Bai Z: Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes. J Cancer 2016, 7(10):1281-1294.
38. Rastogi P, Anderson SJ, Bear HD, Geyer CE, Kahlenberg MS, Robidoux A, Margolese RG, Hoehn JL, Vogel VG, Dakhil SR et al: Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin Oncol 2008, 26(5):778-785.
39. Kong X, Moran MS, Zhang N, Haffty B, Yang Q: Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patients. Eur J Cancer 2011, 47(14):2084-2090.
40. Pauli C, Hopkins BD, Prandi D, Shaw R, Fedrizzi T, Sboner A, Sailer V, Augello M, Puca L, Rosati R et al: Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine. Cancer Discov 2017, 7(5):462-477.
41. Tiriac H, Belleau P, Engle DD, Plenker D, Deschênes A, Somerville TDD, Froeling FEM, Burkhart RA, Denroche RE, Jang GH et al: Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer. Cancer Discov 2018, 8(9):1112-1129.
42. Broutier L, Mastrogiovanni G, Verstegen MM, Francies HE, Gavarró LM, Bradshaw CR, Allen GE, Arnes-Benito R, Sidorova O, Gaspersz MP et al: Human primary liver cancer-derived organoid cultures for disease modeling and drug screening. Nat Med 2017, 23(12):1424-1435.
43. Schütte M, Risch T, Abdavi-Azar N, Boehnke K, Schumacher D, Keil M, Yildiriman R, Jandrasits C, Borodina T, Amstislavskiy V et al: Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors. Nat Commun 2017, 8:14262.